[go: up one dir, main page]

ES2113391T3 - Factor c2a de antibiotico ge 2270. - Google Patents

Factor c2a de antibiotico ge 2270.

Info

Publication number
ES2113391T3
ES2113391T3 ES92113732T ES92113732T ES2113391T3 ES 2113391 T3 ES2113391 T3 ES 2113391T3 ES 92113732 T ES92113732 T ES 92113732T ES 92113732 T ES92113732 T ES 92113732T ES 2113391 T3 ES2113391 T3 ES 2113391T3
Authority
ES
Spain
Prior art keywords
antibiotic
factor
antibiotic factor
medicament
directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92113732T
Other languages
English (en)
Inventor
Enrico Selva
Sergio Stella
Luigi Colombo
Maurizio Denaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosearch Italia SpA
Original Assignee
Biosearch Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch Italia SpA filed Critical Biosearch Italia SpA
Application granted granted Critical
Publication of ES2113391T3 publication Critical patent/ES2113391T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA NUEVA SUSTANCIA ANTIBIOTICA DENOMINADA ANTIBIOTICO GE 2270 FACTOR C2A, LA ADICION DE SALES DEL MISMO, LAS COMPOSICIONES FARMACEUTICAS DEL MISMO Y SU USO COMO MEDICAMENTO, PARTICULARMENTE EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS INCLUYENDO MICROORGANISMOS SUSCEPTIBLES AL MISMO Y SU USO COMO PROMOTOR DEL CRECIMIENTO ANIMAL.
ES92113732T 1991-08-30 1992-08-12 Factor c2a de antibiotico ge 2270. Expired - Lifetime ES2113391T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91114667 1991-08-30

Publications (1)

Publication Number Publication Date
ES2113391T3 true ES2113391T3 (es) 1998-05-01

Family

ID=8207101

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92113732T Expired - Lifetime ES2113391T3 (es) 1991-08-30 1992-08-12 Factor c2a de antibiotico ge 2270.

Country Status (9)

Country Link
US (1) US5514649A (es)
EP (1) EP0529410B1 (es)
JP (1) JP3122248B2 (es)
KR (1) KR100249871B1 (es)
AT (1) ATE163428T1 (es)
CA (1) CA2077102C (es)
DE (1) DE69224497T2 (es)
DK (1) DK0529410T3 (es)
ES (1) ES2113391T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2071143T3 (es) * 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
US5891869A (en) * 1995-02-07 1999-04-06 Biosearch Italia, S.P.A. Basic oxazoline-amide derivatives of GE2270 and GE2270-like antibiotics
CA2212372A1 (en) * 1995-02-07 1996-08-15 Biosearch Italia S.P.A. Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
US6008225A (en) * 1996-02-14 1999-12-28 Biosearch Italia, S.P.A. Derivatives of antibiotic GE2270 factors C2a, D2 and E
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
EP2097423B1 (en) * 2006-12-20 2011-03-02 Novartis AG Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
US8476224B2 (en) 2007-06-04 2013-07-02 Novartis Ag Macrocycles and their uses
CA2708793C (en) 2007-12-12 2016-06-21 Novartis Ag Aminothiazoles and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
DE69016284T2 (de) * 1989-07-04 1995-05-24 Lepetit Spa Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
ES2071143T3 (es) * 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR930004471A (ko) 1993-03-22
DE69224497D1 (de) 1998-04-02
EP0529410A3 (en) 1993-05-26
JP3122248B2 (ja) 2001-01-09
JPH0649087A (ja) 1994-02-22
EP0529410B1 (en) 1998-02-25
DE69224497T2 (de) 1998-07-02
US5514649A (en) 1996-05-07
EP0529410A2 (en) 1993-03-03
ATE163428T1 (de) 1998-03-15
DK0529410T3 (da) 1998-05-11
CA2077102C (en) 2002-11-12
CA2077102A1 (en) 1993-03-01
KR100249871B1 (ko) 2000-03-15

Similar Documents

Publication Publication Date Title
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
EP0473084A3 (en) Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DK0535967T3 (da) Cyclohexapeptidylbisaminforbindelser
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ES2112517T3 (es) Antibioticos ge 37468 a, b y c.
DK0487613T3 (da) Megakarycytopiesk faktor
EP0359062A3 (en) Antibiotic ge 2270
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
ATE117725T1 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
DE68906437D1 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
DK0674645T3 (da) Cephemforbindelser med antimikrobiel virkning

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 529410

Country of ref document: ES